OS by prognostic score in CIMBTR and EBMT cohorts
| CIBMTR . | ||||||
|---|---|---|---|---|---|---|
| . | . | 95% CI . | 95% CI . | . | Overall . | . |
| Rank . | HR . | Lower limit . | Upper limit . | P value . | P value . | n . |
| Low | 1 | Reference | .0002 | 166 | ||
| Intermediate | 1.636 | 1.226 | 2.183 | .0008 | 411 | |
| High | 2.649 | 1.695 | 4.138 | < .0001 | 46 | |
| Contrast | ||||||
| Intermediate vs high | 0.6177 | 0.4186 | 0.9114 | .0152 | ||
| CIBMTR . | ||||||
|---|---|---|---|---|---|---|
| . | . | 95% CI . | 95% CI . | . | Overall . | . |
| Rank . | HR . | Lower limit . | Upper limit . | P value . | P value . | n . |
| Low | 1 | Reference | .0002 | 166 | ||
| Intermediate | 1.636 | 1.226 | 2.183 | .0008 | 411 | |
| High | 2.649 | 1.695 | 4.138 | < .0001 | 46 | |
| Contrast | ||||||
| Intermediate vs high | 0.6177 | 0.4186 | 0.9114 | .0152 | ||
| EBMT . | ||||||
|---|---|---|---|---|---|---|
| . | . | 95% CI . | 95% CI . | . | Overall . | . |
| Rank . | HR . | Lower limit . | Upper limit . | P value . | P value . | n . |
| Low | 1 | Reference | .0011 | 237 | ||
| Intermediate | 1.336 | 1.054 | 1.694 | .0167 | 361 | |
| High | 2.353 | 1.442 | 3.839 | .0006 | 25 | |
| Contrast | ||||||
| Intermediate vs high | 0.5678 | 0.3544 | 0.9097 | .0186 | ||
| EBMT . | ||||||
|---|---|---|---|---|---|---|
| . | . | 95% CI . | 95% CI . | . | Overall . | . |
| Rank . | HR . | Lower limit . | Upper limit . | P value . | P value . | n . |
| Low | 1 | Reference | .0011 | 237 | ||
| Intermediate | 1.336 | 1.054 | 1.694 | .0167 | 361 | |
| High | 2.353 | 1.442 | 3.839 | .0006 | 25 | |
| Contrast | ||||||
| Intermediate vs high | 0.5678 | 0.3544 | 0.9097 | .0186 | ||